1. Aggeler, P.M., O'Reilly, R.A., Leong, L., Kowitz, P.E.: Potentiation of anticoagulant effect of warfarin by phenylbutazone. New Engl. J. Med.276, 496?501 (1967)
2. Beaulieu, E.E., Raynaud, J.P.: A proportion graph method for measuring binding systems. Europ. J. Biochem.13, 293?304 (1970)
3. Branstad, J.O., Meresaar, V., Agren, A.: Complex formation between macromolecules and drugs. VII ? The binding of some barbiturates to human serum albumin (HSA) at varying pH. Acta Pharm. Suecica9, 129?134 (1972)
4. Bridgman, J.F., Rosen, S.M., Thorp, J.M.: Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia. Lancet1972 I, 506?509
5. Burns, J.J., Rose, R.K., C7enkin, T., Goldman, A., Shubert A., Brodie, B.B.: The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J. Pharmacol. (Kyoto)109, 346?357 (1953)